This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
enllacos_rmn [2018/04/04 15:23] miquel [Compostos orgànics] |
enllacos_rmn [2021/09/16 12:49] (current) miquel [Solvents residuals] |
||
|---|---|---|---|
| Line 17: | Line 17: | ||
| * [[http:// | * [[http:// | ||
| + | * [[http:// | ||
| + | * Best Practices | ||
| + | * Chemometrics (Portal Chair: Yulia Monakhova) | ||
| + | * Nomenclature (Portal Chair: John Warren) | ||
| + | * Quantitative NMR (Portal Chair: Elina Zailer) | ||
| + | * 1H High-Precision Quantification | ||
| + | * Reference Material and Data (Portal Co-chairs: Michael Maiwald and Kevin Millis) | ||
| * [[http:// | * [[http:// | ||
| Line 43: | Line 50: | ||
| ==== Solvents residuals ==== | ==== Solvents residuals ==== | ||
| - | | + | === Websites === |
| - | * I. C. Jones, G. J. Sharman, J. Pidgeon. Spectral Assignments and Reference Data. 1-H and 13-C NMR data to aid the identification and quantification of residual solvents by NMR spectroscopy | + | |
| - | * H. E. Gottlieb, V. Kotlyar, A. Nudelman. NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities [[http:// | + | |
| + | |||
| + | === References === | ||
| + | |||
| + | | ||
| + | * H. E. Gottlieb, V. Kotlyar, A. Nudelman. NMR Chemical Shifts of Common Laboratory Solvents as Trace Impurities [[http:// | ||
| + | * G. R. Fulmer, A. J. M. Miller, N H. Sherden, H. E. Gottlieb, A. Nudelman, B. M. Stoltz, J. E. Bercaw, K. I. Goldberg. NMR Chemical Shifts of Trace Impurities: Common Laboratory Solvents, Organics, and Gases in Deuterated Solvents Relevant to the Organometallic Chemist. [[https:// | ||
| ==== Compostos orgànics ==== | ==== Compostos orgànics ==== | ||
| Line 64: | Line 78: | ||
| ==== Predicció de desplaçaments químics ==== | ==== Predicció de desplaçaments químics ==== | ||
| - | * [[http:// | + | === nmrshiftdb === |
| - | | + | |
| - | | + | [[http:// |
| - | * [[http:// | + | |
| - | * Aquest enllaç està estretament relacionat amb el programa [[http:// | + | === NMRdb === |
| - | | + | |
| + | [[http:// | ||
| + | |||
| + | :info: There is a [[http:// | ||
| + | |||
| + | === NMRPREDICT-Server === | ||
| + | |||
| + | [[http:// | ||
| + | * [[http:// | ||
| + | * Aquest enllaç està estretament relacionat amb el programa [[http:// | ||
| + | |||
| + | === ACD/Labs i-Lab === | ||
| + | |||
| + | [[http:// | ||
| ==== Predicció de propietats químiques ==== | ==== Predicció de propietats químiques ==== | ||
| * [[http:// | * [[http:// | ||
| + | * [[https:// | ||
| + | * Scatter plots, box plots, bar charts and pie charts not only visualize numerical or category data, but also show trends of multiple scaffolds or compound substitution patterns. | ||
| + | * Chemical descriptors encode various aspects of chemical structures, e.g. the chemical graph, chemical functionality from a synthetic chemist’s point of view or 3-dimensional pharmacophore features. These allow for fundamentally different types of molecular similarity measures, which can be applied for many purposes including row filtering and the customization of graphical views. | ||
| + | * DataWarrior supports the enumeration of combinatorial libraries as the creation of evolutionary libraries. Compounds can be clustered and diverse subsets can be picked. | ||
| + | * Calculated compound similarities can be used for multidimensional scaling methods, e.g. Kohonen nets. | ||
| + | * Physicochemical properties can be calculated, structure activity relationship tables can be created and activity cliffs be visualized. | ||
| ==== Metabolòmica ==== | ==== Metabolòmica ==== | ||
| Line 141: | Line 174: | ||
| ===== Programari d' | ===== Programari d' | ||
| + | * [[https:// | ||
| * [[http:// | * [[http:// | ||
| * [[http:// | * [[http:// | ||
| Line 155: | Line 189: | ||
| * **evaluation** of the best source of molecules for their projects based upon suppliers' | * **evaluation** of the best source of molecules for their projects based upon suppliers' | ||
| * **expedition** of their drug discovery programs by reducing the barriers, time and costs associated to acquiring molecules. | * **expedition** of their drug discovery programs by reducing the barriers, time and costs associated to acquiring molecules. | ||
| + | * El portal de la [[https:// | ||
| + | * [[https:// | ||
| + | * [[https:// | ||
| + | * [[https:// | ||